Sponsored Links

 

Displaying saxagliptin PowerPoint Presentations



Saxagliptin Assessment of Vascular Outcomes Recorded in ... PPT

Presentation Summary : Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) – TIMI 53. Deepak L. Bhatt, MD, MPHOn behalf of the SAVOR-TIMI 53 ...

Source : http://www.cardiosource.org/~/media/Files/Science%20and%20Quality/Clinical%20Trials/ESC%2013%20Slides/SAVOR-TIMI%2053%20Presentation%20Slides.ashx

Type 2 Diabetes Management Goals - AACE - outpatient.aace.com PPT

Presentation Summary : Linagliptin, saxagliptin, sitagliptin. Reduce dosage for saxagliptin and sitagliptin ifCrCl <50 mg/dL. Dopamine-2 agonist. Bromocriptine. Use with caution. Glinides.

Source : http://outpatient.aace.com/sites/all/files/T2DM-S4-Management-Goals.pptx

Saxagliptin Assessment of Vascular Outcomes Recorded in ... PPT

Presentation Summary : Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) – TIMI 53 Last modified by: Bhatt, Deepak L.,M.D.,M.P.H.

Source : http://cardiometabolic.cardiosource.org/~/media/CardioMetabolic/Images/HTOct13_SAVOR_Slide2.ashx

Glycemic Management in Type 2 Diabetes - outpatient.aace.com PPT

Presentation Summary : Diabetes Obes Metab. 2007;9:194-205. 2. Goldstein BJ, et al. Diabetes Care ... Weight Changes With Saxagliptin: Mono and Combination Therapy. Monotherapy. 24 Weeks. 1.

Source : http://outpatient.aace.com/sites/all/files/T2DM-S5-New-Antidiabetic-Therapies-050613.pptx

Incretin Based Therapy of Type 2 Diabetes Mellitus PPT

Presentation Summary : Some members seem particularly interesting as saxagliptin (? potent) and alogliptin (long acting ... Incretin Based Therapy of Type 2 Diabetes Mellitus Author:

Source : http://www.bibalex.org/diabetessupercourse/DiabetesPPTLectures/Copy%20of%20Incretin%20Based%20Therapy%20of%20Type%202%20Diabetes%20Mellitus_1.ppt

Download - U S Food and Drug Administration Home Page PPT

Presentation Summary : Saxagliptin n/a n/a Ofatumumab rapidly metabolized by hydrolyis of ester linkage; carboxylic acid metabolims further metabolized by glucorondination or oxidation

Source : http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/WomensHealthResearch/UCM272709.ppt

American Diabetes Association - DiabetesPro - Home - American ... PPT

Presentation Summary : standards of medical care in diabetes—2012

Source : http://professional.diabetes.org/SlideLibrary/media/4839/ADA%20Standards%20of%20Medical%20Care%202012%20FINAL.ppt

Use of Combination of Saxagliptin/ Dapagliflozin in Patients ... PPT

Presentation Summary : Author: ETreventi Created Date: 08/21/2014 09:44:30 Title: Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin

Source : http://img.medscape.com/images/827/263/827263_slide.pptx

Projects In Knowledge How to Create a PowerPoint Webcast This ... PPT

Presentation Summary : Garber AJ, et al. Endocr Pract. 2013;19(suppl 2):1-48 ... Both Sitagliptin and Saxagliptin Produced Greatest Reductions in HbA1c in Patients with High Baseline ...

Source : http://www.projectsinknowledge.com/Activity/slides/2189_1.ppt

The Pyramid of Recent Trials - Lipids Online PPT

Presentation Summary : Saxagliptin Monotherapy in Treatment-Naïve Patients with Type 2 Diabetes *P<0.0001 vs PBO BL 4 6 8 12 16 20 24 Weeks Mean ± SE change in A1C from baseline (%) ...

Source : http://lipidsonline.org/ppt_dir/source_ppts/93.ppt

Antidiabetic Medications - University of Washington PPT

Presentation Summary : Antidiabetic Medications Pharm 585 ... 50/1000 mg tablets Saxagliptin (Onglyza) 2.5, 5 mg tablets Saxagliptin/metformin (Kombiglyze XR) 2.5/1000, 5/500, ...

Source : http://courses.washington.edu/pharm585/Antidiabetic%20Medications.ppt

Slide 1 - Scioto County Medical Society PPT

Presentation Summary : ... Multiple targets may lead to unwanted effects on immune function Possible safety issues Vildagliptin, sitagliptin, and saxagliptin Pharmacologic Agents ...

Source : http://sciotocountymedicalsociety.org/documents/Current.Therapy.GLP-1.Sherraden.ppt

Treatment of DM T-2: Then and Now PPT

Presentation Summary : Saxagliptin (Onglyza) 2.5 – 5 mg/day - FDA-approved July 2009 . Can be used as a monotherapy or in combination with metformin or a glitazone.

Source : http://www.fapaonline.org/files/Kotun--Treatment%20of%20DM%20T-2%20final.pptx

Slide 1 PPT

Presentation Summary : Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a ...

Source : http://www.sagarhospitals.in/Uploads/SectionContent/Case%20Study/Ocean%20OF%20Affection/Onglyza%20CME_endo.ppt

Now or Never: The Cardiologist’s Role in Improving CV ... PPT

Presentation Summary : ... SAVOR-TIMI 53 SAVOR-TIMI 53: ... Median Fasting Plasma Glucose PowerPoint Presentation Saxagliptin Assessment of Vascular Outcomes Recorded in Patients ...

Source : http://img.medscape.com/images/812/739/812739_slides.ppt

Diabetes Case Studies - School of Medicine + Health Sciences ... PPT

Presentation Summary : Diabetes Case Studies. Eric L. Johnson, M.D. Assistant Professor. Department of Family and Community Medicine. University of North Dakota School of Medicine

Source : http://www.med.und.edu/familymedicine/slidedecks/documents/DiabetesCaseStudiesPA5-25-11.pptx

TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX PPT

Presentation Summary : * * * * * * * * * * * BCF/ECF Medications MTFs must have BCF meds on formulary UF Medications MTFs ... 50mg/1000mg 03/30/2007 04/24/2017 Saxagliptin Onglyza (BMS ...

Source : http://pec.ha.osd.mil/files/WebcastPECSep11.ppt

Slide 1 PPT

Presentation Summary : Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Source : http://care.diabetesjournals.org/content/suppl/2014/08/22/dc13-2546.DC2/Sept_2014_DC13_2546.ppt

Advances in Diabetic Treatment - NHS West Suffolk Clinical ... PPT

Presentation Summary : Developments in the Treatment of T2DM Dr John Clark New Drug - Dapagliflozin Blocks reabsorption of glucose in kidneys Increased urinary glucose loss Oral medication ...

Source : http://www.westsuffolkccg.nhs.uk/wp-content/uploads/2014/02/John-Clark-New-developments-in-treatment-of-T2DM-Jan-2014.ppt

PowerPoint Presentation PPT

Presentation Summary : ... 2008 Dipeptidyl-Peptidase 4 Inhibitors Agent in Class: Sitagliptin, Saxagliptin Mechanism of action: slows the inactivation of incretin hormones ...

Source : http://ocdiabetesconference.org/wp-content/uploads/2010/01/Oral-Agents-for-9-12-talk-revised.ppt

Slide 1 PPT

Presentation Summary : SAVOR-TIMI 53 Trial design: Patients with type 2 diabetes mellitus (DM2) and established CV disease or multiple risk factors were randomized to either saxagliptin 5 ...

Source : http://cardiometabolic.cardiosource.org/~/media/CardioMetabolic/Images/HTOct13_SAVORTIMI53_Slide1.ashx

Statistical Considerations for Implementing the FDA T2DM CV ... PPT

Presentation Summary : ... possibility of approval for <1.8 when true risk ratio is 1.3 Advisory Committee Meetings Conducted in April 2009 SMQ MACE: CV ... Saxagliptin Onglyza; DPP-4 ...

Source : http://www.amstat.org/chapters/Northeasternillinois/pastevents/presentations/fall09_Wilson.ppt

PowerPoint Presentation PPT

Presentation Summary : Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a ...

Source : http://cmcendovellore.org/downloads/oral-hypoglycemic-agents.ppt

Diabetes Case Studies - School of Medicine + ... PPT

Presentation Summary : Diabetes Case Studies Eric L. Johnson, M.D. Assistant Professor Department of Family and Community Medicine University of North Dakota School of Medicine

Source : http://www.med.und.edu/familymedicine/slidedecks/documents/DiabetesCaseStudies5-12-11.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com